A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists

Health Technol Assess. 2002;6(25):1-160.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Coronary Disease / drug therapy*
  • Coronary Disease / economics*
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / economics*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
  • Thrombolytic Therapy
  • Treatment Outcome
  • United Kingdom

Substances

  • Platelet Aggregation Inhibitors
  • Platelet Glycoprotein GPIIb-IIIa Complex